Moreover, Wells Fargo Com Mn has 0.96% invested in Johnson & Johnson (NYSE:JNJ) for 22.62 million shares. The Guinness Asset Management Ltd holds 90,981 shares with $12.04 million value, up from 79,861 last quarter. Johnson & Johnson Com now has $359.04B valuation. The stock rose 0.28% or $0.37 reaching $133.59. About 587,113 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since October 10, 2016 and is uptrending. It has underperformed by 4.16% the S&P500. The company has market cap of $357.56 billion. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. The Firm provides residential loan services in the United States. Investors of record on Tuesday, August 29th were paid a $0.84 dividend. Its down -0.03, from 0.86 in 2017Q1.
Large investors have recently bought and sold shares of the company. Adi Capital Management Llc who had been investing in Extreme Networks Inc for a number of months, seems to be bullish on the $1.39B market cap company. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Cnbc.com and their article: "J&J shares upgraded by Wells Fargo, which says the third quarter was 'turning ..." published on October 09, 2017 as well as Seekingalpha.com's news article titled: "Johnson & Johnson: Earnings Preview" with publication date: October 10, 2017. Mcf Advisors Llc holds 12,128 shares or 0.32% of its portfolio.
Cambridge Advisors Inc. decreased its stake in Johnson & Johnson (NYSE:JNJ) by 4.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. 916,062 are owned by Everett Harris And Ca. Swift Run Capital Management Ltd holds 0.21% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 2,714 shares. 24,206 were reported by Horizon Kinetics Limited Liability Corporation. Norinchukin Comml Bank The has invested 0.97% in Johnson & Johnson (NYSE:JNJ). Moreover, Ssi Invest Management Incorporated has 0.03% invested in Honeywell International Inc. The firm's 50 day moving average price is $124.35 and its 200-day moving average price is $119.47. Meiji Yasuda Life Insurance stated it has 49,441 shares or 1.01% of all its holdings.
In recent action, Johnson & Johnson (JNJ) has made a move of +0.18% over the past month, which has come on weak relative transaction volume. Five equities research analysts have rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company. Therefore 48% are positive. JNJ was included in 70 notes of analysts from August 7, 2015. BidaskClub upgraded shares of Johnson & Johnson from a "buy" rating to a "strong-buy" rating in a research note on Saturday, June 17th. Atlantic Securities cut shares of Johnson & Johnson from a "neutral" rating to an "underweight" rating and set a $113.00 price objective for the company.in a research note on Friday, July 21st. Societe Generale initiated the stock with "Hold" rating in Wednesday, April 6 report. The firm now has a buy rating on the stock. The rating was maintained by Jefferies on Thursday, July 14 with "Hold". The rating was maintained by BTIG Research with "Sell" on Wednesday, August 2. The firm earned "Hold" rating on Wednesday, September 6 by Jefferies. Jefferies maintained it with "Hold" rating and $145.0 target in Tuesday, August 15 report. The stock of Johnson & Johnson (NYSE:JNJ) has "Buy" rating given on Wednesday, July 19 by UBS. The rating was maintained by BMO Capital Markets on Friday, June 2 with "Buy". Walter Keenan Fincl Consulting Mi Adv reported 3.66% of its portfolio in Johnson & Johnson (NYSE:JNJ). The firm earned "Buy" rating on Tuesday, December 22 by TH Capital.
Analysts await Nationstar Mortgage Holdings Inc (NYSE:NSM) to report earnings on November, 1.
The Average Earnings Estimate for the Current Fiscal quarter is $1.72 per share, according to consensus of 20 analysts. The expected JNJ's profit could reach $4.79 billion giving the stock 18.70 P/E in the case that $1.79 earnings per share is reported. Next quarter's EPS is forecasted at $1.72 with next year's EPS projected to be $7.74. Orexigen Therapeutics, Inc. (NASDAQ:OREX) has declined 15.00% since October 10, 2016 and is downtrending. It has outperformed by 140.98% the S&P500. Capital Va holds 7,257 shares or 0.29% of its portfolio. Buckingham Asset Lc owns 43,275 shares for 1.34% of their portfolio. Peninsula Asset Management invested in 23,501 shares or 2.32% of the stock. Paradigm Asset Mngmt Company Limited Liability Corp invested 0% of its portfolio in Extreme Networks, Inc (NASDAQ:EXTR). Stearns Financial Ser Grp Inc, a North Carolina-based fund reported 54,027 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
NY bridges need $27.4 billion in repairs
Concern about where the funding will come from has grown as the federal government considers funding changes. Here is a list of "structurally deficient" bridges in Erie County from the NYS Comptroller's Office.
Wales v Republic of Ireland - the lessons learned
IRELAND booked their place in the play-off round of the World Cup qualifiers after a famous win over Wales on Monday night. Chris Coleman has offered a coy response to questions about his Wales future, amid interest from West Ham United .